Global Peptide Therapeutics Market Growth (Status and Outlook) 2025-2031

March 2025 | 114 pages | ID: GBAD8868B7D3EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Peptide Therapeutics market size is predicted to grow from US$ 43350 million in 2025 to US$ 74060 million in 2031; it is expected to grow at a CAGR of 9.3% from 2025 to 2031.

Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another.

Global Peptide Therapeutics key players include Sanofi, Novo Nordisk, Takeda, Eli Lilly, Ipsen, etc. Global top five manufacturers hold a share about 65%.

North America is the largest market, with a share about 55%, followed by Europe and Asia-Pacific, both have a share about 40 percent.

In terms of product, Injection is the largest segment, with a share about 70%. And in terms of application, the largest application is Cancer, followed by Central Nervous System.

LPI (LP Information)' newest research report, the “Peptide Therapeutics Industry Forecast” looks at past sales and reviews total world Peptide Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Peptide Therapeutics sales for 2025 through 2031. With Peptide Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peptide Therapeutics industry.

This Insight Report provides a comprehensive analysis of the global Peptide Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Peptide Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Peptide Therapeutics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peptide Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peptide Therapeutics.

This report presents a comprehensive overview, market shares, and growth opportunities of Peptide Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Injection
• Oral
• Other

Segmentation by Application:

• Cancer
• Metabolic Disorders
• Central Nervous System
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Sanofi
• Teva
• Novo Nordisk
• Takeda
• Eli Lilly
• AstraZeneca
• Novartis
• AbbVie
• Ipsen
• Ferring
• Merck
• The Medicines
• J & J

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Peptide Therapeutics Market Size (2020-2031)
  2.1.2 Peptide Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Peptide Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Peptide Therapeutics Segment by Type
  2.2.1 Injection
  2.2.2 Oral
  2.2.3 Other
2.3 Peptide Therapeutics Market Size by Type
  2.3.1 Peptide Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Peptide Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Peptide Therapeutics Segment by Application
  2.4.1 Cancer
  2.4.2 Metabolic Disorders
  2.4.3 Central Nervous System
  2.4.4 Other
2.5 Peptide Therapeutics Market Size by Application
  2.5.1 Peptide Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Peptide Therapeutics Market Size Market Share by Application (2020-2025)

3 PEPTIDE THERAPEUTICS MARKET SIZE BY PLAYER

3.1 Peptide Therapeutics Market Size Market Share by Player
  3.1.1 Global Peptide Therapeutics Revenue by Player (2020-2025)
  3.1.2 Global Peptide Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Peptide Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PEPTIDE THERAPEUTICS BY REGION

4.1 Peptide Therapeutics Market Size by Region (2020-2025)
4.2 Global Peptide Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Peptide Therapeutics Market Size Growth (2020-2025)
4.4 APAC Peptide Therapeutics Market Size Growth (2020-2025)
4.5 Europe Peptide Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Peptide Therapeutics Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Peptide Therapeutics Market Size by Country (2020-2025)
5.2 Americas Peptide Therapeutics Market Size by Type (2020-2025)
5.3 Americas Peptide Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Peptide Therapeutics Market Size by Region (2020-2025)
6.2 APAC Peptide Therapeutics Market Size by Type (2020-2025)
6.3 APAC Peptide Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Peptide Therapeutics Market Size by Country (2020-2025)
7.2 Europe Peptide Therapeutics Market Size by Type (2020-2025)
7.3 Europe Peptide Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Peptide Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Peptide Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Peptide Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PEPTIDE THERAPEUTICS MARKET FORECAST

10.1 Global Peptide Therapeutics Forecast by Region (2026-2031)
  10.1.1 Global Peptide Therapeutics Forecast by Region (2026-2031)
  10.1.2 Americas Peptide Therapeutics Forecast
  10.1.3 APAC Peptide Therapeutics Forecast
  10.1.4 Europe Peptide Therapeutics Forecast
  10.1.5 Middle East & Africa Peptide Therapeutics Forecast
10.2 Americas Peptide Therapeutics Forecast by Country (2026-2031)
  10.2.1 United States Market Peptide Therapeutics Forecast
  10.2.2 Canada Market Peptide Therapeutics Forecast
  10.2.3 Mexico Market Peptide Therapeutics Forecast
  10.2.4 Brazil Market Peptide Therapeutics Forecast
10.3 APAC Peptide Therapeutics Forecast by Region (2026-2031)
  10.3.1 China Peptide Therapeutics Market Forecast
  10.3.2 Japan Market Peptide Therapeutics Forecast
  10.3.3 Korea Market Peptide Therapeutics Forecast
  10.3.4 Southeast Asia Market Peptide Therapeutics Forecast
  10.3.5 India Market Peptide Therapeutics Forecast
  10.3.6 Australia Market Peptide Therapeutics Forecast
10.4 Europe Peptide Therapeutics Forecast by Country (2026-2031)
  10.4.1 Germany Market Peptide Therapeutics Forecast
  10.4.2 France Market Peptide Therapeutics Forecast
  10.4.3 UK Market Peptide Therapeutics Forecast
  10.4.4 Italy Market Peptide Therapeutics Forecast
  10.4.5 Russia Market Peptide Therapeutics Forecast
10.5 Middle East & Africa Peptide Therapeutics Forecast by Region (2026-2031)
  10.5.1 Egypt Market Peptide Therapeutics Forecast
  10.5.2 South Africa Market Peptide Therapeutics Forecast
  10.5.3 Israel Market Peptide Therapeutics Forecast
  10.5.4 Turkey Market Peptide Therapeutics Forecast
10.6 Global Peptide Therapeutics Forecast by Type (2026-2031)
10.7 Global Peptide Therapeutics Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Peptide Therapeutics Forecast

11 KEY PLAYERS ANALYSIS

11.1 Sanofi
  11.1.1 Sanofi Company Information
  11.1.2 Sanofi Peptide Therapeutics Product Offered
  11.1.3 Sanofi Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Sanofi Main Business Overview
  11.1.5 Sanofi Latest Developments
11.2 Teva
  11.2.1 Teva Company Information
  11.2.2 Teva Peptide Therapeutics Product Offered
  11.2.3 Teva Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Teva Main Business Overview
  11.2.5 Teva Latest Developments
11.3 Novo Nordisk
  11.3.1 Novo Nordisk Company Information
  11.3.2 Novo Nordisk Peptide Therapeutics Product Offered
  11.3.3 Novo Nordisk Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Novo Nordisk Main Business Overview
  11.3.5 Novo Nordisk Latest Developments
11.4 Takeda
  11.4.1 Takeda Company Information
  11.4.2 Takeda Peptide Therapeutics Product Offered
  11.4.3 Takeda Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Takeda Main Business Overview
  11.4.5 Takeda Latest Developments
11.5 Eli Lilly
  11.5.1 Eli Lilly Company Information
  11.5.2 Eli Lilly Peptide Therapeutics Product Offered
  11.5.3 Eli Lilly Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Eli Lilly Main Business Overview
  11.5.5 Eli Lilly Latest Developments
11.6 AstraZeneca
  11.6.1 AstraZeneca Company Information
  11.6.2 AstraZeneca Peptide Therapeutics Product Offered
  11.6.3 AstraZeneca Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 AstraZeneca Main Business Overview
  11.6.5 AstraZeneca Latest Developments
11.7 Novartis
  11.7.1 Novartis Company Information
  11.7.2 Novartis Peptide Therapeutics Product Offered
  11.7.3 Novartis Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Novartis Main Business Overview
  11.7.5 Novartis Latest Developments
11.8 AbbVie
  11.8.1 AbbVie Company Information
  11.8.2 AbbVie Peptide Therapeutics Product Offered
  11.8.3 AbbVie Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 AbbVie Main Business Overview
  11.8.5 AbbVie Latest Developments
11.9 Ipsen
  11.9.1 Ipsen Company Information
  11.9.2 Ipsen Peptide Therapeutics Product Offered
  11.9.3 Ipsen Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Ipsen Main Business Overview
  11.9.5 Ipsen Latest Developments
11.10 Ferring
  11.10.1 Ferring Company Information
  11.10.2 Ferring Peptide Therapeutics Product Offered
  11.10.3 Ferring Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Ferring Main Business Overview
  11.10.5 Ferring Latest Developments
11.11 Merck
  11.11.1 Merck Company Information
  11.11.2 Merck Peptide Therapeutics Product Offered
  11.11.3 Merck Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Merck Main Business Overview
  11.11.5 Merck Latest Developments
11.12 The Medicines
  11.12.1 The Medicines Company Information
  11.12.2 The Medicines Peptide Therapeutics Product Offered
  11.12.3 The Medicines Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 The Medicines Main Business Overview
  11.12.5 The Medicines Latest Developments
11.13 J & J
  11.13.1 J & J Company Information
  11.13.2 J & J Peptide Therapeutics Product Offered
  11.13.3 J & J Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.13.4 J & J Main Business Overview
  11.13.5 J & J Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Peptide Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Peptide Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Oral
Table 5. Major Players of Other
Table 6. Peptide Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Peptide Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Peptide Therapeutics Market Size Market Share by Type (2020-2025)
Table 9. Peptide Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Peptide Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Peptide Therapeutics Market Size Market Share by Application (2020-2025)
Table 12. Global Peptide Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Peptide Therapeutics Revenue Market Share by Player (2020-2025)
Table 14. Peptide Therapeutics Key Players Head office and Products Offered
Table 15. Peptide Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Peptide Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Peptide Therapeutics Market Size Market Share by Region (2020-2025)
Table 20. Global Peptide Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Peptide Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Peptide Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Peptide Therapeutics Market Size Market Share by Country (2020-2025)
Table 24. Americas Peptide Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Peptide Therapeutics Market Size Market Share by Type (2020-2025)
Table 26. Americas Peptide Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Peptide Therapeutics Market Size Market Share by Application (2020-2025)
Table 28. APAC Peptide Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Peptide Therapeutics Market Size Market Share by Region (2020-2025)
Table 30. APAC Peptide Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Peptide Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Peptide Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Peptide Therapeutics Market Size Market Share by Country (2020-2025)
Table 34. Europe Peptide Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Peptide Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Peptide Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Peptide Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Peptide Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Peptide Therapeutics
Table 40. Key Market Challenges & Risks of Peptide Therapeutics
Table 41. Key Industry Trends of Peptide Therapeutics
Table 42. Global Peptide Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Peptide Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Peptide Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Peptide Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Sanofi Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 47. Sanofi Peptide Therapeutics Product Offered
Table 48. Sanofi Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Sanofi Main Business
Table 50. Sanofi Latest Developments
Table 51. Teva Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 52. Teva Peptide Therapeutics Product Offered
Table 53. Teva Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Teva Main Business
Table 55. Teva Latest Developments
Table 56. Novo Nordisk Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 57. Novo Nordisk Peptide Therapeutics Product Offered
Table 58. Novo Nordisk Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Novo Nordisk Main Business
Table 60. Novo Nordisk Latest Developments
Table 61. Takeda Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 62. Takeda Peptide Therapeutics Product Offered
Table 63. Takeda Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Takeda Main Business
Table 65. Takeda Latest Developments
Table 66. Eli Lilly Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 67. Eli Lilly Peptide Therapeutics Product Offered
Table 68. Eli Lilly Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Eli Lilly Main Business
Table 70. Eli Lilly Latest Developments
Table 71. AstraZeneca Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 72. AstraZeneca Peptide Therapeutics Product Offered
Table 73. AstraZeneca Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. AstraZeneca Main Business
Table 75. AstraZeneca Latest Developments
Table 76. Novartis Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 77. Novartis Peptide Therapeutics Product Offered
Table 78. Novartis Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Novartis Main Business
Table 80. Novartis Latest Developments
Table 81. AbbVie Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 82. AbbVie Peptide Therapeutics Product Offered
Table 83. AbbVie Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. AbbVie Main Business
Table 85. AbbVie Latest Developments
Table 86. Ipsen Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 87. Ipsen Peptide Therapeutics Product Offered
Table 88. Ipsen Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Ipsen Main Business
Table 90. Ipsen Latest Developments
Table 91. Ferring Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 92. Ferring Peptide Therapeutics Product Offered
Table 93. Ferring Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Ferring Main Business
Table 95. Ferring Latest Developments
Table 96. Merck Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 97. Merck Peptide Therapeutics Product Offered
Table 98. Merck Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Merck Main Business
Table 100. Merck Latest Developments
Table 101. The Medicines Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 102. The Medicines Peptide Therapeutics Product Offered
Table 103. The Medicines Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. The Medicines Main Business
Table 105. The Medicines Latest Developments
Table 106. J & J Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 107. J & J Peptide Therapeutics Product Offered
Table 108. J & J Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. J & J Main Business
Table 110. J & J Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Peptide Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Peptide Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Peptide Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Peptide Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. Peptide Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Peptide Therapeutics Market Size Market Share by Type in 2024
Figure 10. Peptide Therapeutics in Cancer
Figure 11. Global Peptide Therapeutics Market: Cancer (2020-2025) & ($ millions)
Figure 12. Peptide Therapeutics in Metabolic Disorders
Figure 13. Global Peptide Therapeutics Market: Metabolic Disorders (2020-2025) & ($ millions)
Figure 14. Peptide Therapeutics in Central Nervous System
Figure 15. Global Peptide Therapeutics Market: Central Nervous System (2020-2025) & ($ millions)
Figure 16. Peptide Therapeutics in Other
Figure 17. Global Peptide Therapeutics Market: Other (2020-2025) & ($ millions)
Figure 18. Global Peptide Therapeutics Market Size Market Share by Application in 2024
Figure 19. Global Peptide Therapeutics Revenue Market Share by Player in 2024
Figure 20. Global Peptide Therapeutics Market Size Market Share by Region (2020-2025)
Figure 21. Americas Peptide Therapeutics Market Size 2020-2025 ($ millions)
Figure 22. APAC Peptide Therapeutics Market Size 2020-2025 ($ millions)
Figure 23. Europe Peptide Therapeutics Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Peptide Therapeutics Market Size 2020-2025 ($ millions)
Figure 25. Americas Peptide Therapeutics Value Market Share by Country in 2024
Figure 26. United States Peptide Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Peptide Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Peptide Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Peptide Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Peptide Therapeutics Market Size Market Share by Region in 2024
Figure 31. APAC Peptide Therapeutics Market Size Market Share by Type (2020-2025)
Figure 32. APAC Peptide Therapeutics Market Size Market Share by Application (2020-2025)
Figure 33. China Peptide Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Peptide Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Peptide Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Peptide Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. India Peptide Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Peptide Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Peptide Therapeutics Market Size Market Share by Country in 2024
Figure 40. Europe Peptide Therapeutics Market Size Market Share by Type (2020-2025)
Figure 41. Europe Peptide Therapeutics Market Size Market Share by Application (2020-2025)
Figure 42. Germany Peptide Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 43. France Peptide Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Peptide Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Peptide Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Peptide Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Peptide Therapeutics Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Peptide Therapeutics Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Peptide Therapeutics Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Peptide Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Peptide Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Peptide Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Peptide Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Peptide Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Peptide Therapeutics Market Size 2026-2031 ($ millions)
Figure 56. APAC Peptide Therapeutics Market Size 2026-2031 ($ millions)
Figure 57. Europe Peptide Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Peptide Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. United States Peptide Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Canada Peptide Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. Mexico Peptide Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Brazil Peptide Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. China Peptide Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Japan Peptide Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. Korea Peptide Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Peptide Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. India Peptide Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. Australia Peptide Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. Germany Peptide Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. France Peptide Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. UK Peptide Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. Italy Peptide Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. Russia Peptide Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Egypt Peptide Therapeutics Market Size 2026-2031 ($ millions)
Figure 75. South Africa Peptide Therapeutics Market Size 2026-2031 ($ millions)
Figure 76. Israel Peptide Therapeutics Market Size 2026-2031 ($ millions)
Figure 77. Turkey Peptide Therapeutics Market Size 2026-2031 ($ millions)
Figure 78. Global Peptide Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Peptide Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Peptide Therapeutics Market Size 2026-2031 ($ millions)